Actively managed fund

BlueBox Precision Medicine R UK GBP Acc

ISIN
LU2992394382

How good is this fund, really?

See the rating in the app

About BlueBox Precision Medicine R UK GBP Acc

Precision medicine, the trend towards ever more targeted drug development, is the theme of BlueBox Precision Medicine R UK GBP Acc. The sub-fund of BlueBox Funds, a Luxembourg SICAV managed by Carne Global Fund Managers (Luxembourg) S.A., places at least 85% of its assets in shares of pharmaceutical, biotechnology and life science companies worldwide, leaving up to 15% for other industries. Management is active with no benchmark, there are no financial derivatives and the fund is categorised under Article 8 of the SFDR. Returns are retained rather than distributed. Its KIID places it in risk category 7 out of 7 and gives an estimated ongoing charge of 1.54% for this new class, launched on 11 March 2025. Withdrawing within five years may not be appropriate.

Watch this fund for free Add BlueBox Precision Medicine R UK GBP Acc to your watchlist in the PowerFunds app and we tell you when it falls behind the rest of its category.

Watch the fund for free

Where to buy BlueBox Precision Medicine R UK GBP Acc — platforms and fees

Sold on 3 platforms we follow.

BlueBox Precision Medicine R UK GBP Acc — its category

Sector Equity Healthcare — PowerFunds rates 229 funds in this category every month.

Healthcare funds →

Other funds